{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:37:35Z","timestamp":1761183455467,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.dmpk.2014.10.006","type":"journal-article","created":{"date-parts":[[2014,11,16]],"date-time":"2014-11-16T21:27:54Z","timestamp":1416173274000},"page":"142-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Modeling approach for multiple transporters-mediated drug\u2013drug interactions in sandwich-cultured human hepatocytes: Effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide"],"prefix":"10.1016","volume":"30","author":[{"given":"Norikazu","family":"Matsunaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Imawaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikumi","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2014.10.006_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2014.10.006_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/14.3.706","article-title":"Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study","volume":"14","author":"Smak Gregoor","year":"1999","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.dmpk.2014.10.006_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0966-3274(97)80042-1","article-title":"Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in\u00a0vitro findings","volume":"5","author":"Zucker","year":"1997","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00007691-199910000-00008","article-title":"Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients","volume":"21","author":"H\u00fcbner","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dmpk.2014.10.006_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2217\/pgs.10.9","article-title":"Pharmacogenetic influences on mycophenolate therapy","volume":"11","author":"Barraclough","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.dmpk.2014.10.006_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/clpt.2009.205","article-title":"The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics","volume":"87","author":"Picard","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2014.10.006_bib7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2217\/pgs.10.132","article-title":"SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients","volume":"11","author":"Michelon","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.dmpk.2014.10.006_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clpt.2006.08.002","article-title":"Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients","volume":"80","author":"Naesens","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2014.10.006_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/mp400513k","article-title":"Mathematical modeling of the in\u00a0vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes","volume":"11","author":"Matsunaga","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.dmpk.2014.10.006_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.18.16","article-title":"Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans","volume":"18","author":"Horikawa","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"year":"2012","series-title":"Guidance for industry: drug interaction studies \u2013 study design, data analysis, implications for dosing, and labeling recommendations","author":"The United States Federal Drug Agency","key":"10.1016\/j.dmpk.2014.10.006_bib12"},{"year":"2012","series-title":"Guideline on the investigation of drug interactions","author":"The European Medicines Agency","key":"10.1016\/j.dmpk.2014.10.006_bib13"},{"key":"10.1016\/j.dmpk.2014.10.006_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/clpt.2013.81","article-title":"In\u00a0vitro methods to support transporter evaluation in drug discovery and development","volume":"94","author":"Brouwer","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2014.10.006_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in\u00a0vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmpk.2014.10.006_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2133\/dmpk.DMPK-13-NT-049","article-title":"More relevant prediction for in\u00a0vivo drug interaction of candesartan cilexetil on hepatic bile acid transporter BSEP using sandwich-cultured hepatocytes","volume":"29","author":"Fukuda","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.dmpk.2014.10.006_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.109.156653","article-title":"Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation","volume":"332","author":"Lee","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmpk.2014.10.006_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.112.049817","article-title":"Evaluation of hepatic disposition of paroxetine using sandwich-cultured rat and human hepatocytes","volume":"41","author":"Matsunaga","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2014.10.006_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1139\/Y10-060","article-title":"Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes","volume":"88","author":"Hartman","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.taap.2012.06.016","article-title":"Application of quantitative time-lapse imaging (QTLI) for evaluation of Mrp2-based drug-drug interaction induced by liver metabolites","volume":"263","author":"Nakanishi","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.2006.02509.x","article-title":"A\u00a0comparison of the effect of ciclosporin and sirolimus on the pharmacokinetics of mycophenolate in renal transplant patients","volume":"62","author":"Picard","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1124\/dmd.111.038968","article-title":"Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes","volume":"39","author":"Kotani","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2014.10.006_bib23","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfm632","article-title":"Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients","volume":"23","author":"Falck","year":"2008","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.dmpk.2014.10.006_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2005.02398.x","article-title":"Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling","volume":"60","author":"Cremers","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0091270009332813","article-title":"Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: assessment of impact of cyclosporine dose in Asian renal transplant patients","volume":"49","author":"Yau","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/0091270009335003","article-title":"Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients","volume":"49","author":"Naito","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2014.10.006_bib27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1124\/dmd.106.009290","article-title":"Drug-drug interaction between pitavastatin and various drugs via OATP1B1","volume":"34","author":"Hirano","year":"2006","journal-title":"Drug Metab Dispos"},{"year":"2013","series-title":"Label information of NEORAL\u00ae in the United States of America","key":"10.1016\/j.dmpk.2014.10.006_bib28"},{"key":"10.1016\/j.dmpk.2014.10.006_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.103.063073","article-title":"Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats","volume":"309","author":"Kobayashi","year":"2004","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.dmpk.2014.10.006_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/dmd.105.006122","article-title":"Role of Mrp2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: effect of cyclosporine","volume":"34","author":"Westley","year":"2006","journal-title":"Drug Metab Dispos"},{"year":"2004","series-title":"Drug approval package of Myforic\u00ae for the United States Federal Drug Agency","key":"10.1016\/j.dmpk.2014.10.006_bib31"},{"key":"10.1016\/j.dmpk.2014.10.006_bib32","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11095-009-9924-0","article-title":"The role of transporters in the pharmacokinetics of orally administered drugs","volume":"26","author":"Shugarts","year":"2009","journal-title":"Pharm Res"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436714000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436714000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:52:07Z","timestamp":1761162727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436714000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1347436714000159"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2014.10.006","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling approach for multiple transporters-mediated drug\u2013drug interactions in sandwich-cultured human hepatocytes: Effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2014.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}